v3.24.3

Significant Transactions (Tables) - RubrYc Therapeutics | 12 Months Ended
--- | ---
Jun. 30, 2024
Asset Purchase Agreement |
Summary of Purchase Price Allocation of Asset Acquisition | ​
​ | ​ | ​ | ​
Intangible assets | ​ | $ | 1,228,000
Fixed assets | ​ | ​ | 114,000
​ | ​ | $ | 1,342,000
Stock Purchase Agreement |
Summary of Purchase Price Allocation of Asset Acquisition | The Company accounted for the agreements as an asset purchase and allocated the purchase price of $7,500,000 as follows: ​
​ | ​ | ​ | ​
Preferred stock | ​ | $ | 1,760,000
Intangible assets | ​ | ​ | 4,300,000
Prepaid expenses | ​ | ​ | 1,440,000
​ | ​ | $ | 7,500,000

X
- Definition Tabular disclosure of asset acquisition. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3 + Details
Name: | us-gaap_AssetAcquisitionTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=ibio_RubrycTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=ibio_AssetPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ibio_StockPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |